September 28, 2015

Mylan’s latest generic, recently approved by the Food and Drug Administration, is intended to treat schizophrenia and schizoaffective disorder.

September 28, 2015
According to a new report from Bloomberg, Target has expanded its list of chemicals that it wants suppliers to remove from their products. The list includes almost 600 substances on Health Canada’s roster of prohibited cosmetic ingredients, such as coal tars and bisphenol A. It also adds triclosan, an antibacterial ingredient that is under review in hand soaps and sanitizers by the FDA.
September 18, 2015

The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works. 

September 18, 2015

Mylan on Friday launched its generic version of Lescol XL (fluvastatin sodium) extended-release tablets.

September 17, 2015

Camber Pharmaceuticals announced this week that it had launched generics of GlaxoSmithKline’s Valtrex (valacyclovir) and Eisai’s Aricept (donepezil).

September 17, 2015

Aurobindo Pharma’s received approval from the Food and Drug Administration this week for its generic of Roxane Laboratories’ Dolophine (methadone HCL) tablets. 

September 11, 2015

Egalet Corporation on Thursday launched (oxycodone HCI) in the U.S.

September 11, 2015

Using Xerox’s prescription clinical authorization tool, pharmacists can investigate whether a patient recently received an opioid prescription and will receive a notice to acquire prior authorization before dispensing it. 

September 10, 2015

Prilosec OTC will donate $125,000 to Taste of the NFL on Feb. 6, 2016, the company stated.

September 4, 2015

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

September 3, 2015

Lupin Pharmaceuticals on Thursday announced the launch of its duloxetine delayed-release, a generic version of Cymbalta.

August 26, 2015

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

August 24, 2015

Camber Pharmaceuticals last week announced its introduction of its entecavir tablet in 0.5- and 1-mg dosage strengths.

August 21, 2015

Galderma Laboratories has announced that Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5%, is available in retail pharmacies nationwide and in Puerto Rico. 

August 20, 2015

For this installment of DSN’s Executive Viewpoint series, DSN spoke to Menasha’s Paul Murphy about how Menasha is working to bridge the merchandising strategy gap between pharmacists and front-of-store, which can help improve care.

August 20, 2015

GlaxoSmithKline’s Flonase may not be on today’s top five bestselling cough-cold-allergy-sinus products list, but it won’t be long until the brand breaks through.

August 20, 2015

Since the launch of Nexium 24HR in May of 2014, the brand has generated approximately $300 million, “making it one of the largest and most successful Rx-to-OTC switches,” Ian Read, Pfizer chairman and CEO, recently told analysts.

August 19, 2015

The company is one of the first to launch a generic version of the discontinued Abilify Oral Solution used to treat depression, bipolar disorder and schizophrenia. 

August 19, 2015

A study conducted by researchers at Johns Hopkins Bloomberg School of Public Health has found that Florida’s legislative efforts to curb opioid abuse seem to be having their desired effect. 

August 18, 2015

Aurobindo Pharma Limited announced Tuesday that it had received approval from the Food and Drug Administration for its over-the-counter cetirizine hydrochloride in 5- and 10-mg dosage strengths.

August 17, 2015

The website includes sections about the importance of preventing abuse of prescription drugs and outlines the Food and Drug Administrations guidelines on abuse-deterrent labeling. 

August 11, 2015

Iressa is a once-daily oral medication that targets and blocks the activity of epidermal growth factor receptor-tyrosine kinase.

August 10, 2015

According to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4% of the population) live with substance use disorders.